Transforming paediatric asthma management: The role of dupilumab in reshaping treatment paradigms
Asthma is the most common chronic respiratory disease in children. Understand how type 2 inflammation drives the severity of their disease, increasing exacerbation risk and leading to poor disease control
Learning objectives
You will learn:
- What is problematic severe asthma
- The importance of type 2 inflammation in paediatric asthma
- The role of biomarkers in asthma management
- The practice use of biologic therapies in paediatric asthma management
- Evidence on the efficacy and safety of dupilumab.
To access this module, please register or login: